China Universal Asset Management Company’s Bicycle Therapeutics BCYC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$31.5K Sell
7,420
-802
-10% -$3.68K ﹤0.01% 482
2026
Q1
$38.1K Buy
8,222
+682
+9% +$3.9K ﹤0.01% 472
2025
Q4
$53.4K Sell
7,540
-564
-7% -$4.16K ﹤0.01% 444
2025
Q3
$62.7K Sell
8,104
-762
-9% -$5.75K 0.01% 416
2025
Q2
$61.6K Buy
8,866
+33
+0.4% +$263 0.01% 407
2025
Q1
$75K Sell
8,833
-496
-5% -$5.84K 0.01% 383
2024
Q4
$131K Buy
9,329
+2,191
+31% +$47K 0.01% 367
2024
Q3
$162K Buy
7,138
+2,918
+69% +$67.3K 0.02% 317
2024
Q2
$85.4K Sell
4,220
-2,639
-38% -$59.6K 0.01% 311
2024
Q1
$171K Buy
6,859
+2,858
+71% +$60.7K 0.02% 312
2023
Q4
$72.3K Buy
4,001
+3,322
+489% +$55K 0.01% 322
2023
Q3
$13.6K Buy
679
+340
+100% +$7.78K ﹤0.01% 326
2023
Q2
$8.65K Sell
339
-10
-3% -$232 ﹤0.01% 327
2023
Q1
$7.42K Buy
349
+90
+35% +$2.26K ﹤0.01% 332
2022
Q4
$7.67K Buy
259
+20
+8% +$537 ﹤0.01% 252
2022
Q3
$6K Buy
+239
New +$5.69K ﹤0.01% 246

Other funds holding BCYC

China Universal Asset Management Company's BCYC Position: Q2 2026 in Review

China Universal Asset Management Company reduced its Bicycle Therapeutics (BCYC) stake by 9.8% in Q2 2026, selling an estimated $3.68K and leaving 7,420 shares worth $31.5K. The position accounts for ﹤0.01% of the portfolio, ranked #482.

China Universal Asset Management Company first reported a position in BCYC in Q3 2022 and has held it in 16 quarters since. The position peaked at $171K in Q1 2024. 27 funds tracked by Wall St. Rank hold BCYC as of Q2 2026.

  • China Universal Asset Management Company held 7,420 shares of Bicycle Therapeutics worth $31.5K as of Q2 2026.
  • China Universal Asset Management Company sold 802 Bicycle Therapeutics shares in Q2 2026, an estimated $3.68K.
  • Bicycle Therapeutics made up ﹤0.01% of China Universal Asset Management Company's portfolio in Q2 2026, its #482 holding.
  • China Universal Asset Management Company first reported a position in Bicycle Therapeutics in Q3 2022 and has held it in 16 quarters since.
  • China Universal Asset Management Company's Bicycle Therapeutics position peaked at $171K in Q1 2024.
  • 27 funds tracked by Wall St. Rank held Bicycle Therapeutics as of Q2 2026.

Based on China Universal Asset Management Company's 13F filing for Q2 2026, filed 24 Jul 2026.